InnovAge - INNV Short Interest Ratio & Short Volume

Short interest is the volume of InnovAge shares that have been sold short but have not yet been closed out or covered. As of February 14th, investors have sold 4,000 shares of INNV short. Learn More on InnovAge's current short interest.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of InnovAge: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

InnovAge saw a decrease in short interest in February. As of February 14th, there was short interest totaling 4,000 shares, a decrease of 31.0% from the previous total of 5,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to InnovAge: U.S. Physical Therapy, Inc. (8.47%), The Pennant Group, Inc. (3.01%), CRH Medical Co. (0.00%), OrthoPediatrics Corp. (10.97%), Ardelyx, Inc. (1.36%), Rhythm Pharmaceuticals, Inc. (5.16%), Biohaven Ltd. (16.64%), Cassava Sciences, Inc. (9.84%), and uniQure (14.34%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Tesla, Inc. ($11.87 billion), Charter Communications, Inc. ($5.15 billion), Microchip Technology Incorporated ($2.98 billion), Match Group, Inc. ($2.25 billion), The Charles Schwab Co. ($2.09 billion), Simon Property Group, Inc. ($2.06 billion), Tiffany & Co. ($1.81 billion), Hormel Foods Co. ($1.66 billion), Omnicom Group Inc. ($1.61 billion), and International Flavors & Fragrances Inc. ($1.54 billion). View all of the most shorted stocks.

Short selling INNV is an investing strategy that aims to generate trading profit from InnovAge as its price is falling. INNV shares are trading up $0.33 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for InnovAge occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INNV, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INNV, twice per month. The most recent reporting period available is February, 14 2020.